top of page
Search

My Daughter Wants to Take Ozempic, But She is Already Thin. Is it Safe?

Writer: Susan McClanahan, Ph.D. & Angela Derrick, Ph.D.
Susan McClanahan, Ph.D. & Angela Derrick, Ph.D.
2 hours ago
10 min read
A group of college-aged girls, sorority sisters, sitting on a sofa.

This article is part of our broader guide to GLP-1 medications and your mental health. For the full picture of how these medications affect mood, body image, and eating, start there.


Your daughter may still be in high school, or home from college, or on the phone from her dorm room, and she has asked you to help her get Ozempic. She is not overweight. If anything, she may already be slim. She has friends who are doing it, maybe a whole sorority house of them, and she talks about it the way people talk about a juice cleanse: as something ordinary, manageable, the kind of thing everyone is doing. She might even suggest she will only "microdose," a small amount, nothing drastic.


And you are standing in the kitchen trying to figure out what to say, because a big part of you understands the pressure she is under, and another part of you is frightened, wondering, is this safe? What could be the harm in it?


Here is the short answer, and then we will explain it. For a young woman who is not overweight and has no medically indicated reason to take a GLP-1, these medications can pose real risk with little legitimate benefit. Calling it "microdosing" does not make it safe. If your daughter is already thin and/or has a weight in the healthy range according to BMI, and wants one of these drugs to become smaller, pay attention. The concern here isn't really about a number on the scale; it's about using a strong medication to lose weight there's no medical reason to lose. Wanting this is understandable. But that wish can be the leading edge of an eating disorder, and these medications can be unusually effective at turning it into one.


Non-medically indicated GLP-1 use is happening at ever-increasing rates in our younger generations. In September 2026, The Cut published a feature by Angelina Chapin, "How Far Would You Go for Sisterhood?", reporting that college women are injecting themselves with GLP-1s every week to win bids from the most competitive sororities. Students in the article called it an "Ozempidemic," with one saying, "everyone is taking it, but nobody is talking about it." The reporting also describes mothers who are on these medications themselves and helping their daughters obtain them too. The pressures on everyone are hard to miss.


What is "Microdosing"?


It helps to start here, because the word is doing a lot of reassuring work it hasn't earned.


"Microdosing" a GLP-1 means taking smaller doses than the standard prescribed amounts: dividing a higher dose into several shots to save money, staying on the lowest starting dose, or going below even that. There are no standardized guidelines for it, and the American Diabetes Association does not endorse it. The term has a certain wellness-culture glow, borrowed from the world of psychedelic microdosing, and that glow is part of why it sounds relatively harmless.


The reality is a little more complicated. Much of the microdosing happening now involves compounded versions of these drugs, which are not reviewed by the FDA and are not all mixed to the same concentration, so a "small" dose can deliver more medication than a person intends. Drug levels can swing instead of staying steady. And a great deal of it is obtained online, from vendors who will ship the medication without a meaningful medical evaluation, without confirming that the person has any condition the drug is meant to treat, and without anyone in the picture who would recognize a developing eating disorder.


So when your daughter says she will "just microdose," what she is often describing is taking an unregulated amount of a powerful medication, obtained without medical oversight, to lose weight she does not medically need to lose. The smallness of the dose is not the protection it may sound like.


What Ozempic Can and Can’t Do When There’s No Medical Reason to Take It


GLP-1 medications are a genuine medical advance. For people with type 2 diabetes or obesity, they can be life-changing, and we have seen this firsthand. Our concern is specific: it is about what these drugs do in the body of someone who does not need medical weight management.


GLP-1s work by suppressing appetite and slowing digestion, which puts the body into a state of eating much less than it otherwise would. For a person with excess weight to lose, that negative energy balance is the point, and it is managed. For a young woman who is already at a healthy weight, the same mechanism means something very different. It pushes her into exactly the physiological state that defines restriction: eating less than her body needs, losing weight she did not have to lose, and often feeling rewarded by everyone around her for doing it.


That combination, biological restriction plus social praise, is close to a textbook recipe for a restrictive eating disorder. And here is the part that surprises many parents: you cannot tell whether someone has an eating disorder just by looking at them. The current diagnostic criteria for anorexia no longer require a person to be severely underweight, and by one estimate from the National Association of Anorexia Nervosa and Associated Disorders, only about 6 percent of people with eating disorders are medically underweight. A young woman can be developing a serious, even severe, restrictive eating disorder while still looking, to the outside world, merely slim and disciplined.


What these medications can’t do is deliver what she is really after. They can't give a young woman confidence or belonging, or relieve her of the feeling and belief that her body is the problem. That kind of relief comes from hard psychological and behavioral health work. The wish underneath the request is real. It is just not something a medication can meet.


Do GLP-1s Cause Eating Disorders? The Evidence So Far


This is not a hypothetical worry. It is a concern that eating-disorder specialists and major medical journals are raising directly.


In a 2026 perspective in the New England Journal of Medicine, physician Amanda Banks laid out the problem plainly. The share of GLP-1 prescriptions written for people without diabetes, obesity, or overweight rose from about 4.5 percent in 2018 to 17 percent in 2023. While these drugs show early promise as a treatment for binge eating disorder, there is also compelling preliminary evidence that they can worsen and even trigger new cases of restrictive eating disorders, including anorexia nervosa, a condition with one of the highest mortality rates in psychiatry.


The risk is not evenly spread. It concentrates in people who already have a mental health condition, and that matters here, because the young women most drawn to these drugs for appearance are often the same ones already living with anxiety, depression, or a history of disordered eating.


In one analysis of more than 60,000 people taking GLP-1s, about 1.28 percent were diagnosed with an eating disorder within two years. That can sound small, until you consider what it counts: a serious, sometimes life-threatening illness, newly appearing within two years in people who did not have it before. And people who already had a mental health condition were more than twice as likely to develop one as those who did not.


Across the tens of millions of Americans now taking these drugs, a rate like that scales fast. Banks projected that if roughly one in eight Americans takes a GLP-1, more than 420,000 people could develop an eating disorder, and warned that physicians, regulators, and drug developers are "unprepared for this coming wave."


What makes an eating disorder especially hard to catch is that the people most at risk often do not look sick, and the clinicians prescribing the drugs, frequently through telehealth or online vendors, are often not trained to screen for eating disorders at all. No standard screening protocol exists before these medications are prescribed. The safeguard that should exist, someone asking, "Is there a history of disordered eating here?" before handing over an appetite suppressant, frequently is not there.


"By the time a young woman looks unwell, the eating disorder usually has a long head start," says Dr. Susan McClanahan, Co-Founder of SpringSource. "What concerns us about these medications is how easily they turn an ordinary wish to lose weight into a restrictive pattern that is very hard to undo."

Why Ozempic Is Spreading Among Young Women


There is a reason this hits young women harder than almost anyone else, and it says something uncomfortable about the world we live in.


The pressure to be thin has always been part of our culture; it has just found a powerful new tool. On college campuses and across the parts of social media where young women spend their time, thinness is still treated as a kind of currency, something that buys belonging, status, and approval. When a medication appears that seems to deliver those results quickly, and when it spreads through a friend or peer group, abstaining from it can feel like opting out of the entire game. For a nineteen-year-old, that is an enormous thing to ask.


We can't help but note that this pressure falls almost entirely on young women; the young men around them are rarely asked to shrink themselves the same way. And the cost is high. The energy a young woman pours into becoming smaller is energy she is not pouring into becoming herself. Into her education, her friendships, her ambitions. Into discovering who she is apart from her body. That is its own kind of loss.


From the Parent Who Procures to the Parent Who Protects


Here is the part that is hard to say, and we are going to say it with as much warmth as we can, because we know the position you are in.


If you have found yourself tempted to help your daughter obtain a GLP-1 medication, you are far from alone, and it does not make you a bad parent. Maybe you are on one yourself and understand the appeal. Maybe it feels safer to supervise it than to have her source it online. Maybe you just cannot bear to watch your child feel like an outsider, and you remember your own painful history with weight and want to spare her that. Every one of those impulses comes from love, or from a pressure you feel too.


But helping her obtain a GLP-1 she does not medically need is not the protective act it can feel like in the moment. It hands her a tool that can set a restrictive eating disorder in motion, and it subtly confirms the belief underneath her request: that her current body is a problem to be solved. The most protective thing you can do here is usually the harder thing, which is not to procure the medication, but to become curious, together, about why she wants it so badly.


That does not mean lecturing her, or shaming her, or treating her request as proof that something is wrong with her. It means getting underneath it. What is she hoping will change when she is thinner? What is she afraid will happen if she does not do this? Where did she get the idea that her body, as it is, is not acceptable? Those questions, asked with genuine compassion rather than alarm, tend to open far more than a flat-out no ever could.


What Parents Can Do


If your daughter has expressed a desire to start taking a GLP-1 medication, here are a few suggestions that tend to help.


Take her request seriously without treating it as an emergency. A wish to be thinner is extremely common and does not, by itself, mean she has an eating disorder. But it is an area to explore carefully, because what may be hidden behind the request matters.


Do not supply the medication. This is the clearest line. Obtaining a GLP-1 for an already-thin young woman or a young woman simply in a healthy weight range, or helping her get one, means handing her the exact tool that may turn body dissatisfaction into something more serious.


Watch for the signs that distinguish ordinary body worry from something clinical: a growing preoccupation with food, calories, or weight; eating less and less, or developing rigid food rules; weighing or body-checking frequently; withdrawing from meals or social eating; excessive exercise; mood changes, irritability, or anxiety around food; and rapid weight loss. Any of these, especially in combination, is a reason to reach out to a professional who understands eating disorders.


Look honestly at the messages at home, too. This is not about blame. But a daughter absorbs a great deal from how the adults around her talk about their bodies, their dieting, and their weight. A parent's steadiness about their own body is one of the most protective things a young woman can witness, and it is covered more fully in our piece on what families with teenagers need to know when a parent is on a GLP-1.


Get support early rather than waiting for a crisis. Eating disorders are far more treatable the sooner they are addressed, and you do not have to wait until something is clearly wrong to talk to someone. If you are unsure, that uncertainty is reason enough to reach out.


What Should I Do If My Daughter Is Already Taking Ozempic?


If you have found out your daughter is already on a GLP-1, the first thing to know is that this is workable, and the way you respond now matters more than how it started.


Resist the urge to make it a confrontation. An angry ultimatum, or taking the medication away overnight, tends to drive the whole thing underground. The goal is to stay close enough that she feels safe talking to you.


Find out where the medication is coming from. If it's from an online vendor or a friend, there's likely no clinician monitoring her, and that absence is a major risk factor. Getting a qualified medical provider into the picture, someone who can evaluate her honestly, is one of the most useful steps you can take.


Do not ask her to stop abruptly on her own. Whether and how to come off a GLP-1 is a decision for a medical provider, not something to improvise at the kitchen table.


Most importantly, get an eating-disorder-informed assessment. The real question is not only whether the drug is safe for her. It is whether a restrictive pattern is already taking hold, and you can't rule that out by how she looks. The signs above are a place to start, but a clinician who understands eating disorders can tell you far more than a checklist can.


How SpringSource Can Help


At SpringSource: Eating, Weight & Mood Disorders, this is squarely our work. We help families through this exact moment: when a daughter wants or is already taking a medicine that worries you, and you are not sure how to respond in a way that protects her without pushing her away. And we work directly with young women on the pressure, body image, and relationship with food that lie beneath their request for a GLP-1.


Our approach is weight-inclusive and non-shaming, toward your daughter and toward you. We don't see a young woman's wish to be thinner as a character flaw, and we don't cast a worried parent as the problem. We treat it as what it usually is: a signal that someone is under real pressure, and that deserves care rather than alarm.


If any of this sounds like you or your family, we would be glad to help you think it through. Call us at 224-202-6260, fill out our contact form, or schedule online.


For a more complete clinical picture of how these medications and eating disorders interact, see our companion piece, GLP-1 Medications and Eating Disorders: A Complicated Relationship.


Sources

Comments

bottom of page